Blog
8 October, 2024
The closing table of the 5th Symposium of the Healthcare Observatory reviewed the challenges facing the sector. Spain, as a leader of a European health policy’. […]
27 September, 2024
The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), is a single entry point for the submission and assessment of clinical trial […]
26 September, 2024
From R&D to pharmacovigilance to production and incremental innovation, the industry is constantly seeking to maximise risk reduction in medicines. On World Patient Safety Day, WHO […]
24 September, 2024
Artificial intelligence applied to medical research, top technology trend in 2024 according to the World Economic Forum. Farmaindustria.es Artificial intelligence (AI) is a true revolution […]
19 September, 2024
The report highlights the sector’s contribution to the EU’s R&D and trade balance and recognises the worrying trend of Europe losing ground to other regions of […]
17 September, 2024
The Director General of Farmaindustria, Juan Yermo, presents the sector’s potential and challenges on the second day of the 23rd Annual Meeting of the Pharmaceutical Industry […]
30 July, 2024
1 THE BRAND-NAME DRUG COSTS THE SAME AS ITS GENERIC DRUG Farmaindustria.es Brand-name drugs are at the same price as generic drugs in Spain. The […]
23 July, 2024
For the first time, China has overtaken Europe as the creator of new active ingredients, with 25 compared to the 17 of the old continent, and […]
10 July, 2024
EL PAÍS and Farmaindustria address the tasks pending to achieve autonomy in the manufacture of pharmaceuticals. Elpais.com Spain stands out for its strong pharmaceutical industry. It […]
9 July, 2024
A hundred members of the Spanish Society of Family and Community Medicine and pharmaceutical companies attend a training session to learn about the opportunities offered to […]
25 June, 2024
After its presentation a few months ago in Andalusia, the guide to bring clinical trials to health centres has been disseminated in Castilla y León and […]
17 June, 2024
The Association has participated in the Forum on clinical trials organised by the United Nations in the Latin American and Caribbean region together with the Latin […]
23 May, 2024
Spain is a benchmark country in the world and the first in Europe to conduct clinical trials to test the safety and efficacy of new drugs. […]
15 May, 2024
Its application should also serve to put an end to repetitive and inefficient evaluations and guarantee rigour for patients and healthcare professionals, who will play an […]
13 May, 2024
Recruitment forecasts for innovative pharmaceutical companies for the coming years exceed 10,000 new jobs for the under-30s. The website offers practical information about the sector and […]
30 April, 2024
Funcas and Farmaindustria held a conference on ‘The economic regulation of the pharmaceutical industry. Current situation and future prospects in Spain’, which was attended by more […]
24 April, 2024
Spain is at the forefront of research. Experts discuss the potential of new medicines at a forum organised by EL PAÍS and Farmaindustria. Elpais.com In the […]
22 April, 2024
DemócrataPRO brings together the Health Commission to debate on the reform of the law on medicines On 21 March, DemócrataPro brought together the spokespersons of the […]
3 April, 2024
The Spanish Technological Platform for Innovative Medicines, led by Farmaindustria, has been promoting public-private collaboration projects in clinical and pre-clinical research since 2005. “Spain currently occupies […]
2 April, 2024
Human papillomavirus is responsible for 95% of cervical tumours. Since 2006, several vaccines have been licensed that can prevent most cases. In Spain, the autonomous communities […]
19 March, 2024
The health sector, essential for the well-being of the population and an economic engine for society
fundacionidis.com The ecosystem of the private healthcare sector transcends the field of healthcare and has an impact on society and on the productive sectors of the […]
7 March, 2024
There are 146 orphan drugs approved by the European Medicines Agency. Spain has only 81 in its catalogue. It has rejected funding for 25 and is […]
5 March, 2024
Research into new drugs for rare diseases has multiplied in recent years. In Spain, industry drives 90% of clinical trials for this type of disease. One […]
13 February, 2024
In a press release, the Andalusian Regional Government highlights the joint commitment of both entities to continue advancing in the promotion of R&D&I, following the meeting […]
8 February, 2024
Of the 1,944 clinical trials authorised in the European Union through the new European Information System, Spanish centres participated in 845, or 43% of the total. […]
6 February, 2024
The European Medicines Agency has thus identified nine oncology approvals for 2023. The arrival of new treatments is directly linked to the pharmaceutical industry’s commitment to […]
2 February, 2024
The Technological Platform for Innovative Medicines – whose Coordination Committee is made up of 10 representatives from the pharmaceutical industry and 10 representatives from public research […]
1 February, 2024
Farmaindustria welcomes the presentation by the Ministry of Health of the harmonised catalogue of genetic tests for the whole country. For this catalogue to become a […]
30 January, 2024
The US expert unpacked the data from his study on the relationship between pharmaceutical innovation and cancer mortality in Spain between 1999 and 2016 in a […]
15 January, 2024
Infectious diseases, neurological diseases, type 2 diabetes in children, oncology and cardiac disorders are just some of the areas that benefited from the innovation drive last […]
28 January, 2020
They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]